Sustainable Development - Our Commitment
Our Commitment
Search
Lameness – a common problem in horses
The causes of lameness, and why there is a clear need for innovation and new treatment options.
Central Nervous System Diseases
Find out more about our research and development in central nervous system diseases
Fighting against rabies through vaccination and education
Dr. Silvina Muñiz is sharing her insights about rabies prevention and explains why education is essential.
Patient Organizations
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations.
The Neuroscience Gallery
Take a guided tour through our virtual 3-D Neuroscience art exhibition, with Clinical Program Leader, Dr. Michael Sand.
More Potential Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Partnering Culture
Partnering Culture
Immuno-Oncology
We are unlocking the broader possibilities of immuno-oncology, taking cancer on through the power of the body’s immune system.
Expectations towards our business partners
We utilize an extensive network of international suppliers for procuring raw materials, intermediates, packaging materials, technical components and services to deliver our innovative medications worldwide.
Boehringer Ingelheim Announces $1.14 Million Support for Lebanon
Boehringer Ingelheim Announces $1.14 Million Support for Lebanon
Respiratory Diseases
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in respiratory diseases.
Immunology Respiratory Research
Find out more about our research and development in Immunology & Respiratory diseases
FuturePack
Boehringer Ingelheim has built a new special machine that enables efficient and sustainable packaging of small batches.
Effective vaccine against most virulent strains of Marek's disease affecting poultry
Effective vaccine against most virulent strains of Marek's disease affecting poultry launched in Egypt
Boehringer Ingelheim collaborates with local universities in Nairobi, Kenya to introduce
Boehringer Ingelheim collaborates with local universities in Nairobi, Kenya to introduce development program for young professionals
Bigger role in ensuring food security
As the world population is projected to reach 9.8 billion in 2050, animal health becomes fundamental to ensure both animal well-being and global protein supply.
View from Both Sides of the Table
Scott DeWire, US Head of BD&L shares experiences that have taught him first-hand the foundations of successful partnerships
Boehringer Ingelheim inaugurates new milestone on its long-term commitment to the Kingdom
Boehringer Ingelheim inaugurates new milestone on its long-term commitment to the Kingdom
Equiphoria helping stroke patients hippotherapy
To further research, we're partnering with Equiphoria, a French therapy center for hippotherapy.
Boehringer Ingelheim Saudi Arabia Hosts Virtual Summit on the Latest Updates in Diabetes, Cardio
Boehringer Ingelheim Saudi Arabia Hosts Virtual Summit on the Latest Updates in Diabetes, Cardio-Metabolism, Respiratory Diseases and Stroke Management
Partnering in Central Nervous System Diseases
We are looking for new early-science collaborations. Join our expanding community of innovation partners in central nervous system diseases.
Contact us
Find all our contact information here about our BD&L team.
Boehringer Ingelheim commences local production of first batch of antihypertensive medicines
Boehringer Ingelheim commences local production of first batch of antihypertensive medicines in Algeria
Supply Chain Scholarship for Cowtribe
A supply chain course we sponsored boosted the career of Latifa Saaka